BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9450477)

  • 1. Induction of DNA adducts and mutations in spleen, liver and lung of XPA-deficient/lacZ transgenic mice after oral treatment with benzo[a]pyrene: correlation with tumour development.
    de Vries A; Dollé ME; Broekhof JL; Muller JJ; Kroese ED; van Kreijl CF; Capel PJ; Vijg J; van Steeg H
    Carcinogenesis; 1997 Dec; 18(12):2327-32. PubMed ID: 9450477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice.
    Hoogervorst EM; de Vries A; Beems RB; van Oostrom CT; Wester PW; Vos JG; Bruins W; Roodbergen M; Cassee FR; Vijg J; van Schooten FJ; van Steeg H
    Carcinogenesis; 2003 Mar; 24(3):613-9. PubMed ID: 12663525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
    Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
    Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.
    Kucab JE; van Steeg H; Luijten M; Schmeiser HH; White PA; Phillips DH; Arlt VM
    Mutat Res; 2015 Mar; 773():48-62. PubMed ID: 25847421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated frequencies of benzo(a)pyrene-induced Hprt mutations in internal tissue of XPA-deficient mice.
    Bol SA; van Steeg H; Jansen JG; Van Oostrom C; de Vries A; de Groot AJ; Tates AD; Vrieling H; van Zeeland AA; Mullenders LH
    Cancer Res; 1998 Jul; 58(13):2850-6. PubMed ID: 9661901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.
    John K; Pratt MM; Beland FA; Churchwell MI; McMullen G; Olivero OA; Pogribny IP; Poirier MC
    Carcinogenesis; 2012 Nov; 33(11):2236-41. PubMed ID: 22828138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice.
    van Steeg H; Mullenders LH; Vijg J
    Mutat Res; 2000 May; 450(1-2):167-80. PubMed ID: 10838141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential mutagenicity and cytotoxicity of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol and (+/-)-anti-benzo[a]pyrene-trans-7,8-dihydrodiol-9,10-epoxide in genetically engineered human fibroblasts.
    Quan T; Reiners JJ; Culp SJ; Richter P; States JC
    Mol Carcinog; 1995 Feb; 12(2):91-102. PubMed ID: 7662121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors.
    Ide F; Iida N; Nakatsuru Y; Oda H; Tanaka K; Ishikawa T
    Carcinogenesis; 2000 Jun; 21(6):1263-5. PubMed ID: 10837020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
    van Steeg H; Klein H; Beems RB; van Kreijl CF
    Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.
    Kucab JE; Zwart EP; van Steeg H; Luijten M; Schmeiser HH; Phillips DH; Arlt VM
    DNA Repair (Amst); 2016 Mar; 39():21-33. PubMed ID: 26723900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP).
    Imaida K; Ogawa K; Takahashi S; Ito T; Yamaguchi T; Totsuka Y; Wakabayashi K; Tanaka K; Ito N; Shirai T
    Cancer Lett; 2000 Mar; 150(1):63-9. PubMed ID: 10755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.
    de Vries A; van Oostrom CT; Dortant PM; Beems RB; van Kreijl CF; Capel PJ; van Steeg H
    Mol Carcinog; 1997 May; 19(1):46-53. PubMed ID: 9180928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra.
    Boerrigter ME
    Environ Mol Mutagen; 1999; 34(2-3):140-7. PubMed ID: 10529738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XP-A cells complemented with Arg228Gln and Val234Leu polymorphic XPA alleles repair BPDE-induced DNA damage better than cells complemented with the wild type allele.
    Porter PC; Mellon I; States JC
    DNA Repair (Amst); 2005 Mar; 4(3):341-9. PubMed ID: 15661657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
    Ginsberg GL; Atherholt TB
    Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated accumulation of somatic mutations in mice deficient in the nucleotide excision repair gene XPA.
    Giese H; Dollé ME; Hezel A; van Steeg H; Vijg J
    Oncogene; 1999 Feb; 18(5):1257-60. PubMed ID: 10022133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation.
    Suh M; Ariese F; Small GJ; Jankowiak R; Hewer A; Phillips DH
    Carcinogenesis; 1995 Oct; 16(10):2561-9. PubMed ID: 7586167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.